Immix Biopharma
Price & Volume
Stats
See moreOpen | $9.85 |
Previous Close | $9.85 |
Day Range | $9.77-$10.15 |
52W Range | $1.60-$11.60 |
Market Cap | $513.6M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.89 |
News
See moreYahoo Finance • 16 days ago
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
Yahoo Finance • 4 months ago
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance • 4 months ago
Immix Soars On NXC-201 Data In Relapsed/Refractory AL Amyloidosis; BLA Planned For 2026
About
CEO | Dr. Ilya Rachman M.B.A., M.D., Ph.D. |
CFO | Mr. Gabriel Morris B.A. |
Address | 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
